STAAR Surgical (STAA) Tops Q1 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
May 4, 2022 4:01 PM EDTEVO Visian® ICL Lenses Received FDA Approval and First Lenses Implanted
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 1, 2022.
First Quarter 2022 Overview
Record Net Sales of $63.2 Million Up 25% from the Prior Year Quarter ICL Sales of $58.7 Million Up 26% from the Prior Year... More